Warning: file_get_contents(http://tehnika-news.ru/shells.txt): failed to open stream: Connection refused in /var/sites/p/paperbomb.com/public_html/meds2/1/index.php on line 2
how is besponsa administered

how is besponsa administered

Перейти к контенту

Главное меню:

how is besponsa administered
Taking BESPONSA® | BESPONSA®, Besponsa | European Medicines Agency, Besponsa: Uses, Side Effects, Benefits/Risks | Drugs.com, About BESPONSA® | BESPONSA®, Drug Trials Snapshots: BESPONSA, BESPONSA 1 mg powder for concentrate for solution for , Besponsa (Inotuzumab ozogamicin) Drug / Medicine Information, BILLING AND CODING INFORMATION FOR HOSPITAL OUTPATIENT, Besponsa New FDA Drug Approval | CenterWatch.
BESPONSA can cause liver problems that can be severe, life-threatening, or fatal, including a condition called veno-occlusive disease (VOD). This condition can occur during treatment with BESPONSA or following subsequent treatment with a stem cell transplant. This condition was more common in patients who had elevated liver tests or who received dual alkylating agents in preparation for their stem cell transplant. Patients may be at a higher risk of VOD if they: . BESPONSA is a prescription medicine given over a 1-hour period by intravenous (IV) infusion. IV infusion may be the same way you received chemotherapy treatments in the past. IV infusion may be the same way you received chemotherapy treatments in the past.. In patients who do not respond to treatment, Besponsa should be stopped after 3 cycles. Besponsa can only be obtained with a prescription, and treatment should be given under the supervision of a doctor who has experience in the use of cancer treatments. For further information, see the package leaflet..
Besponsa is given as an infusion (drip) into a vein lasting for at least one hour. The infusions are given on days 1, 8 and 15 of a 3 or 4 week treatment cycle. The doctor may interrupt treatment or reduce the dose, if the patient develops certain serious side effects.. BESPONSA is a type of medicine called an antibody-drug conjugate. BESPONSA is designed to find and attach to a specific protein, called CD22, found on leukemia cells BESPONSA is designed to find and attach to a specific protein, called CD22, found on leukemia cells. BESPONSA is given by a healthcare provider directly into the bloodstream through a needle in the vein. This is known as an intravenous, or IV infusion. It takes about one hour to receive BESPONSA . BESPONSA should be administered under the supervision of a physician experienced in the use of cancer therapy and in an environment where full resuscitation facilities are immediately available. When considering the use of BESPONSA as a treatment for relapsed or refractory B cell ALL, baseline CD22 positivity of > 0% using a validated and sensitive assay is required prior to initiating treatment (see section 5.1).. Besponsa is given in "cycles". One Besponsa treatment cycle is made up of a single Besponsa dose given each week for 3 weeks. A doctor or nurse will give you your Besponsa dose gradually over 1 . BESPONSA is administered by 1-hour IV infusion on Days 1, 8, and 15 of each 3- to 4-week cycle. BESPONSA is supplied as a 0.9 mg single-dose vial. Each vial is reconstituted with 4 mL of Sterile Water for Injection, USP, to obtain a concentration of Please refer to the full Prescribing Information for complete Dosage and Administration instructions. Administration3,5 (CPT®) The information .
Copyright 2019. All rights reserved.
Назад к содержимому | Назад к главному меню